Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Emerging and reemerging infectious diseases: the perpetual challenge.

Identifieur interne : 004849 ( Main/Exploration ); précédent : 004848; suivant : 004850

Emerging and reemerging infectious diseases: the perpetual challenge.

Auteurs : Anthony S. Fauci [États-Unis]

Source :

RBID : pubmed:16306276

Descripteurs français

English descriptors

Abstract

Public health officials once suggested that it might someday be possible to "close the book" on the study and treatment of infectious diseases. However, it is now clear that endemic diseases as well as newly emerging ones (e.g., severe acute respiratory syndrome [SARS]), reemerging ones (e.g., West Nile virus), and even deliberately disseminated infectious diseases (e.g., anthrax from bioterrorism) continue to pose a substantial threat throughout the world. Over the past several decades, the global effort to identify and characterize infectious agents, decipher the underlying pathways by which they cause disease, and develop preventive measures and treatments for many of the world's most dangerous pathogens has helped control many endemic diseases. But despite considerable progress, infectious diseases continue to present significant challenges as new microbial threats emerge and reemerge. HIV/AIDS, malaria, tuberculosis, influenza, SARS, West Nile virus, Marburg virus, and bioterrorism are examples of some of the emerging and reemerging threats. In responding to these ongoing challenges, a new paradigm in countermeasure development is needed. In the past, U.S. government-sponsored biomedical researchers have focused on basic research and concept development, leaving product development to the pharmaceutical industry. Increasingly, however, the government has become involved in more targeted countermeasure development efforts. In this regard, partnerships between government, industry, and academia are necessary as we struggle to maintain and update our armamentarium in the struggle to outwit the microbes that pose a never-ending threat to mankind.

DOI: 10.1097/00001888-200512000-00002
PubMed: 16306276


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Emerging and reemerging infectious diseases: the perpetual challenge.</title>
<author>
<name sortKey="Fauci, Anthony S" sort="Fauci, Anthony S" uniqKey="Fauci A" first="Anthony S" last="Fauci">Anthony S. Fauci</name>
<affiliation wicri:level="2">
<nlm:affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg 31, Room 7A03, MSC 2520, 9000 Rockville Pike, Bethesda, MD 20892-2520, USA. afauci@niaid.nih.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg 31, Room 7A03, MSC 2520, 9000 Rockville Pike, Bethesda, MD 20892-2520</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16306276</idno>
<idno type="pmid">16306276</idno>
<idno type="doi">10.1097/00001888-200512000-00002</idno>
<idno type="wicri:Area/PubMed/Corpus">002436</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002436</idno>
<idno type="wicri:Area/PubMed/Curation">002436</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002436</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002733</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002733</idno>
<idno type="wicri:Area/Ncbi/Merge">001276</idno>
<idno type="wicri:Area/Ncbi/Curation">001276</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001276</idno>
<idno type="wicri:doubleKey">1040-2446:2005:Fauci A:emerging:and:reemerging</idno>
<idno type="wicri:Area/Main/Merge">004B50</idno>
<idno type="wicri:Area/Main/Curation">004849</idno>
<idno type="wicri:Area/Main/Exploration">004849</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Emerging and reemerging infectious diseases: the perpetual challenge.</title>
<author>
<name sortKey="Fauci, Anthony S" sort="Fauci, Anthony S" uniqKey="Fauci A" first="Anthony S" last="Fauci">Anthony S. Fauci</name>
<affiliation wicri:level="2">
<nlm:affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg 31, Room 7A03, MSC 2520, 9000 Rockville Pike, Bethesda, MD 20892-2520, USA. afauci@niaid.nih.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg 31, Room 7A03, MSC 2520, 9000 Rockville Pike, Bethesda, MD 20892-2520</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Academic medicine : journal of the Association of American Medical Colleges</title>
<idno type="ISSN">1040-2446</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Biomedical Research (trends)</term>
<term>Communicable Diseases, Emerging</term>
<term>Drug Industry</term>
<term>Federal Government</term>
<term>Humans</term>
<term>Public Health</term>
<term>Risk Assessment</term>
<term>United States</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Gouvernement fédéral</term>
<term>Humains</term>
<term>Industrie pharmaceutique</term>
<term>Maladies transmissibles émergentes</term>
<term>Recherche biomédicale (tendances)</term>
<term>Santé publique</term>
<term>États-Unis d'Amérique</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr">
<term>Recherche biomédicale</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en">
<term>Biomedical Research</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Communicable Diseases, Emerging</term>
<term>Drug Industry</term>
<term>Federal Government</term>
<term>Humans</term>
<term>Public Health</term>
<term>Risk Assessment</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Gouvernement fédéral</term>
<term>Humains</term>
<term>Industrie pharmaceutique</term>
<term>Maladies transmissibles émergentes</term>
<term>Santé publique</term>
<term>États-Unis d'Amérique</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Public health officials once suggested that it might someday be possible to "close the book" on the study and treatment of infectious diseases. However, it is now clear that endemic diseases as well as newly emerging ones (e.g., severe acute respiratory syndrome [SARS]), reemerging ones (e.g., West Nile virus), and even deliberately disseminated infectious diseases (e.g., anthrax from bioterrorism) continue to pose a substantial threat throughout the world. Over the past several decades, the global effort to identify and characterize infectious agents, decipher the underlying pathways by which they cause disease, and develop preventive measures and treatments for many of the world's most dangerous pathogens has helped control many endemic diseases. But despite considerable progress, infectious diseases continue to present significant challenges as new microbial threats emerge and reemerge. HIV/AIDS, malaria, tuberculosis, influenza, SARS, West Nile virus, Marburg virus, and bioterrorism are examples of some of the emerging and reemerging threats. In responding to these ongoing challenges, a new paradigm in countermeasure development is needed. In the past, U.S. government-sponsored biomedical researchers have focused on basic research and concept development, leaving product development to the pharmaceutical industry. Increasingly, however, the government has become involved in more targeted countermeasure development efforts. In this regard, partnerships between government, industry, and academia are necessary as we struggle to maintain and update our armamentarium in the struggle to outwit the microbes that pose a never-ending threat to mankind.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Maryland">
<name sortKey="Fauci, Anthony S" sort="Fauci, Anthony S" uniqKey="Fauci A" first="Anthony S" last="Fauci">Anthony S. Fauci</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004849 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004849 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16306276
   |texte=   Emerging and reemerging infectious diseases: the perpetual challenge.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16306276" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021